Natriuretic peptide control of energy balance and glucose homeostasis

Biochimie

Volumn 124, Issue , 2016, Pages 84-91

  Coué, Marine ^a,b   Moro, Cedric ^a,b,c  

^a Université de Toulouse   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c CHU RANGUEIL   (France)

Author keywords

cGMP; Lipid metabolism; Natriuretic peptides; Obesity; Skeletal muscle; Type 2 diabetes

Indexed keywords

INSULIN; NATRIURETIC FACTOR; PROTEINASE; GLUCOSE;

CARDIOVASCULAR DISEASE; DEGRADATION; DISEASE ASSOCIATION; ENERGY BALANCE; ENERGY EXPENDITURE; EXERCISE; FOOD INTAKE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATION; PROTEIN SECRETION; REVIEW; THERMOGENESIS; ANIMAL; BROWN ADIPOSE TISSUE; ENERGY METABOLISM; METABOLISM; MOUSE; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GLUCOSE; HUMANS; MICE; NATRIURETIC PEPTIDES; OBESITY;

EID: 84930443018     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2015.05.017     Document Type: Review

References (106)

1. A.J. de Bold, and T.G. Flynn Cardionatrin I - a novel heart peptide with potent diuretic and natriuretic properties Life Sci. 33 1983 297 302
2. M. Lafontan, C. Moro, M. Berlan, F. Crampes, C. Sengenes, and J. Galitzky Control of lipolysis by natriuretic peptides and cyclic GMP Trends Endocrinol. Metab. 19 2008 130 137
3. C. Moro, and M. Lafontan Natriuretic peptides and cGMP signaling control of energy homeostasis Am. J. Physiol. Heart Circ. Physiol. 304 2013 H358 H368
4. M. Bordicchia, D. Liu, E.Z. Amri, G. Ailhaud, P. Dessi-Fulgheri, C. Zhang, and et al. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes J. Clin. Invest. 122 2012 1022 1036
5. S. Engeli, A.L. Birkenfeld, P.M. Badin, V. Bourlier, K. Louche, N. Viguerie, and et al. Natriuretic peptides enhance the oxidative capacity of human skeletal muscle J. Clin. Invest. 122 2012 4675 4679
6. T.J. Wang, M.G. Larson, D. Levy, E.J. Benjamin, E.P. Leip, P.W. Wilson, and et al. Impact of obesity on plasma natriuretic peptide levels Circulation 109 2004 594 600
7. P. Dessi-Fulgheri, R. Sarzani, P. Tamburrini, A. Moraca, E. Espinosa, G. Cola, and et al. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients J. Hypertens. 15 1997 1695 1699
8. A.M. Khan, S. Cheng, M. Magnusson, M.G. Larson, C. Newton-Cheh, E.L. McCabe, and et al. Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies J. Clin. Endocrinol. Metab. 96 2011 3242 3249
9. G.A. Walford, Y. Ma, C.A. Christophi, R.B. Goldberg, P. Jarolim, E. Horton, and et al. Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program Diabetologia 57 2014 935 939
10. M. Magnusson, A. Jujic, B. Hedblad, G. Engstrom, M. Persson, J. Struck, and et al. Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study J. Clin. Endocrinol. Metab. 97 2012 638 645
11. 2-terminal pro-brain natriuretic peptide and risk of diabetes Diabetes 62 2013 3189 3193
12. D.G. Gardner, S. Chen, D.J. Glenn, and C.L. Grigsby Molecular biology of the natriuretic peptide system: implications for physiology and hypertension Hypertension 49 2007 419 426
13. L.R. Potter Natriuretic peptide metabolism, clearance and degradation FEBS J. 278 2011 1808 1817
14. G. Gruden, A. Landi, and G. Bruno Natriuretic peptides, heart, and adipose tissue: new findings and future developments for diabetes research Diabetes Care 37 2014 2899 2908
15. L.C. Costello-Boerrigter, H. Lapp, G. Boerrigter, A. Lerman, A. Bufe, F. Macheret, and et al. Secretion of prohormone of B-type natriuretic peptide, proBNP1-108, is increased in heart failure JACC Heart Fail. 1 2013 207 212
16. M. Kim, M.J. Platt, T. Shibasaki, S.E. Quaggin, P.H. Backx, S. Seino, and et al. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure Nat. Med. 19 2013 567 575
17. C.J. Li, Q. Yu, P. Yu, T.L. Yu, Q.M. Zhang, S. Lu, and et al. Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients Cardiovasc. Diabetol. 13 2014 36
18. A. Asmar, L. Simonsen, M. Asmar, S. Madsbad, J.J. Holst, E. Frandsen, and et al. Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men Am. J. Physiol. Endocrinol. Metab. 308 8 2015 E641 E649 ajpendo 00429 02014
19. J.A. Lovshin, A. Barnie, A. DeAlmeida, A. Logan, B. Zinman, and D.J. Drucker Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes Diabetes Care 38 2014 132 139
20. G. Barletta, L. Stefani, R. Del Bene, C. Fronzaroli, S. Vecchiarino, C. Lazzeri, and et al. Effects of exercise on natriuretic peptides and cardiac function in man Int. J. Cardiol. 65 1998 217 225
21. A. Kjaer, J. Appel, P. Hildebrandt, and C.L. Petersen Basal and exercise-induced neuroendocrine activation in patients with heart failure and in normal subjects Eur. J. Heart Fail. 6 2004 29 39
22. A. Mandroukas, T.I. Metaxas, J. Heller, E. Vamvakoudis, K. Christoulas, C.S. Riganas, and et al. The effect of different exercise-testing protocols on atrial natriuretic peptide Clin. Physiol. Funct. Imaging 31 2011 5 10
23. I.C. Steele, G. McDowell, A. Moore, N.P. Campbell, C. Shaw, K.D. Buchanan, and et al. Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects Eur. J. Clin. Invest. 27 1997 270 276
24. M. Kato, T. Kinugawa, K. Ogino, A. Endo, S. Osaki, O. Igawa, and et al. Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left ventricular dysfunction and congestive heart failure J. Intern. Med. 248 2000 309 315
25. C. Moro, F. Crampes, C. Sengenes, I. De Glisezinski, J. Galitzky, C. Thalamas, and et al. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans FASEB J. 18 2004 908 910
26. H. Hamasaki, H. Yanai, M. Kakei, M. Noda, and O. Ezaki The association between daily physical activity and plasma B-type natriuretic peptide in patients with glucose intolerance: a cross-sectional study BMJ Open 5 2015 e006276
27. K.S. Misono, J.S. Philo, T. Arakawa, C.M. Ogata, Y. Qiu, H. Ogawa, and et al. Structure, signaling mechanism and regulation of the natriuretic peptide receptor guanylate cyclase FEBS J. 278 2011 1818 1829
28. M. Kuhn Cardiac and intestinal natriuretic peptides: insights from genetically modified mice Peptides 26 2005 1078 1085
29. N. Matsukawa, W.J. Grzesik, N. Takahashi, K.N. Pandey, S. Pang, M. Yamauchi, and et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system Proc. Natl. Acad. Sci. U. S. A. 96 1999 7403 7408
30. M.B. Anand-Srivastava Natriuretic peptide receptor-C signaling and regulation Peptides 26 2005 1044 1059
31. R. Garg, and K.N. Pandey Regulation of guanylyl cyclase/natriuretic peptide receptor-A gene expression Peptides 26 2005 1009 1023
32. R. Sarzani, P. Dessi-Fulgheri, F. Salvi, M. Serenelli, D. Spagnolo, G. Cola, and et al. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives J. Hypertens. 17 1999 1301 1305
33. R. Sarzani, P. Strazzullo, F. Salvi, R. Iacone, F. Pietrucci, A. Siani, and et al. Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity Obes. Res. 12 2004 351 356
34. R. Sarzani, V.M. Paci, C.M. Zingaretti, C. Pierleoni, S. Cinti, G. Cola, and et al. Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue J. Hypertens. 13 1995 1241 1246
35. K. Miyashita, H. Itoh, H. Tsujimoto, N. Tamura, Y. Fukunaga, M. Sone, and et al. Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity Diabetes 58 2009 2880 2892
36. H. Nakatsuji, N. Maeda, T. Hibuse, A. Hiuge, A. Hirata, Y. Kuroda, and et al. Reciprocal regulation of natriuretic peptide receptors by insulin in adipose cells Biochem. Biophys. Res. Commun. 392 2010 100 105
37. O. Pivovarova, O. Gogebakan, N. Kloting, A. Sparwasser, M.O. Weickert, I. Haddad, and et al. Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity? J. Clin. Endocrinol. Metab. 97 2012 E731 E739
38. J.E. Olerud, M.L. Usui, D. Seckin, D.S. Chiu, C.L. Haycox, I.S. Song, and et al. Neutral endopeptidase expression and distribution in human skin and wounds J. Invest. Dermatol. 112 1999 873 881
39. P. Muangman, M.L. Spenny, R.N. Tamura, and N.S. Gibran Fatty acids and glucose increase neutral endopeptidase activity in human microvascular endothelial cells Shock 19 2003 508 512
40. M.G. Spillantini, F. Sicuteri, S. Salmon, and B. Malfroy Characterization of endopeptidase 3.4.24.11 ("enkephalinase") activity in human plasma and cerebrospinal fluid Biochem. Pharmacol. 39 1990 1353 1356
41. S. Zraika, D.S. Koh, B.M. Barrow, B. Lu, S.E. Kahn, and S. Andrikopoulos Neprilysin deficiency protects against fat-induced insulin secretory dysfunction by maintaining calcium influx Diabetes 62 2013 1593 1601
42. K.F. Standeven, K. Hess, A.M. Carter, G.I. Rice, P.A. Cordell, A.J. Balmforth, and et al. Neprilysin, obesity and the metabolic syndrome Int. J. Obes. (Lond.) 35 2011 1031 1040
43. E.G. Bevan, J.M. Connell, J. Doyle, H.A. Carmichael, D.L. Davies, A.R. Lorimer, and et al. Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension J. Hypertens. 10 1992 607 613
44. L.M. Ruilope, A. Dukat, M. Bohm, Y. Lacourciere, J. Gong, and M.P. Lefkowitz Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study Lancet 375 2010 1255 1266
45. I. Brandt, A.M. Lambeir, J.M. Ketelslegers, M. Vanderheyden, S. Scharpe, and I. De Meester Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form Clin. Chem. 52 2006 82 87
46. M. Sauve, K. Ban, M.A. Momen, Y.Q. Zhou, R.M. Henkelman, M. Husain, and et al. Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice Diabetes 59 2010 1063 1073
47. L.A. Ralat, Q. Guo, M. Ren, T. Funke, D.M. Dickey, L.R. Potter, and et al. Insulin-degrading enzyme modulates the natriuretic peptide-mediated signaling response J. Biol. Chem. 286 2011 4670 4679
48. J.P. Maianti, A. McFedries, Z.H. Foda, R.E. Kleiner, X.Q. Du, M.A. Leissring, and et al. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones Nature 511 2014 94 98
49. D.G. Gardner Natriuretic peptides: markers or modulators of cardiac hypertrophy? Trends Endocrinol. Metab. 14 2003 411 416
50. S.J. Wieczorek, A.H. Wu, R. Christenson, P. Krishnaswamy, S. Gottlieb, T. Rosano, and et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation Am. Heart J. 144 2002 834 839
51. K. Maeda, T. Tsutamoto, A. Wada, N. Mabuchi, M. Hayashi, T. Tsutsui, and et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure J. Am. Coll. Cardiol. 36 2000 1587 1593
52. P. Li, Y. Luo, and Y.M. Chen B-type natriuretic peptide-guided chronic heart failure therapy: a meta-analysis of 11 randomised controlled trials Heart Lung Circ. 22 2013 852 860
53. S. Engeli Role of the renin-angiotensin-aldosterone system in the metabolic syndrome Contrib. Nephrol. 151 2006 122 134
54. M.R. Mehra, P.A. Uber, M.H. Park, R.L. Scott, H.O. Ventura, B.C. Harris, and et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure J. Am. Coll. Cardiol. 43 2004 1590 1595
55. J.A. Taylor, R.H. Christenson, K. Rao, M. Jorge, and S.S. Gottlieb B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures Am. Heart J. 152 2006 1071 1076
56. V. Cannone, G. Boerrigter, A. Cataliotti, L.C. Costello-Boerrigter, T.M. Olson, P.M. McKie, and et al. A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community J. Am. Coll. Cardiol. 58 2011 629 636
57. A. Jujic, P.M. Nilsson, G. Engstrom, B. Hedblad, O. Melander, and M. Magnusson Atrial natriuretic peptide and type 2 diabetes development-biomarker and genotype association study PLoS One 9 2014 e89201
58. C. Moro Natriuretic peptides and fat metabolism Curr. Opin. Clin. Nutr. Metab. Care 16 2013 645 649
59. R. Sarzani, P. Dessi-Fulgheri, V.M. Paci, E. Espinosa, and A. Rappelli Expression of natriuretic peptide receptors in human adipose and other tissues J. Endocrinol. Invest. 19 1996 581 585
60. C. Sengenes, A. Bouloumie, H. Hauner, M. Berlan, R. Busse, M. Lafontan, and et al. Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes J. Biol. Chem. 278 2003 48617 48626
61. C. Sengenes, M. Berlan, I. De Glisezinski, M. Lafontan, and J. Galitzky Natriuretic peptides: a new lipolytic pathway in human adipocytes FASEB J. 14 2000 1345 1351
62. C. Moro, J. Polak, B. Richterova, C. Sengenes, T. Pelikanova, J. Galitzky, and et al. Differential regulation of atrial natriuretic peptide- and adrenergic receptor-dependent lipolytic pathways in human adipose tissue Metabolism 54 2005 122 131
63. C. Moro, F. Pillard, I. De Glisezinski, I. Harant, D. Riviere, V. Stich, and et al. Training enhances ANP lipid-mobilizing action in adipose tissue of overweight men Med. Sci. Sports Exercise 37 2005 1126 1132
64. C. Moro, M. Pasarica, K. Elkind-Hirsch, and L.M. Redman Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome J. Clin. Endocrinol. Metab. 94 2009 2579 2586
65. J. Polak, C. Moro, E. Klimcakova, M. Kovacikova, M. Bajzova, M. Vitkova, and et al. The atrial natriuretic peptide- and catecholamine-induced lipolysis and expression of related genes in adipose tissue in hypothyroid and hyperthyroid patients Am. J. Physiol. Endocrinol. Metab. 293 2007 E246 E251
66. J. Polak, M. Kotrc, Z. Wedellova, A. Jabor, I. Malek, J. Kautzner, and et al. Lipolytic effects of B-type natriuretic peptide 1-32 in adipose tissue of heart failure patients compared with healthy controls J. Am. Coll. Cardiol. 58 2011 1119 1125
67. T. Agustsson, M. Ryden, J. Hoffstedt, V. van Harmelen, A. Dicker, J. Laurencikiene, and et al. Mechanism of increased lipolysis in cancer cachexia Cancer Res. 67 2007 5531 5537
68. C. Sengenes, A. Zakaroff-Girard, A. Moulin, M. Berlan, A. Bouloumie, M. Lafontan, and et al. Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 2002 R257 R265
69. B. Haas, P. Mayer, K. Jennissen, D. Scholz, M. Berriel Diaz, W. Bloch, and et al. Protein kinase G controls brown fat cell differentiation and mitochondrial biogenesis Sci. Signal. 2 2009 ra78
70. M.M. Mitschke, L.S. Hoffmann, T. Gnad, D. Scholz, K. Kruithoff, P. Mayer, and et al. Increased cGMP promotes healthy expansion and browning of white adipose tissue FASEB J. 27 2013 1621 1630
71. S.C. Souza, M.D. Chau, Q. Yang, M.S. Gauthier, K.B. Clairmont, Z. Wu, and et al. Atrial natriuretic peptide regulates lipid mobilization and oxygen consumption in human adipocytes by activating AMPK Biochem. Biophys. Res. Commun. 410 2011 398 403
72. E. Plante, A. Menaouar, B.A. Danalache, T.L. Broderick, M. Jankowski, and J. Gutkowska Treatment with brain natriuretic peptide prevents the development of cardiac dysfunction in obese diabetic db/db mice Diabetologia 57 2014 1257 1267
73. C. Moro, E. Klimcakova, K. Lolmede, M. Berlan, M. Lafontan, V. Stich, and et al. Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue Diabetologia 50 2007 1038 1047
74. J.R. Brestoff, and D. Artis Immune regulation of metabolic homeostasis in health and disease Cell 161 2015 146 160
75. O. Tsukamoto, M. Fujita, M. Kato, S. Yamazaki, Y. Asano, A. Ogai, and et al. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure J. Am. Coll. Cardiol. 53 2009 2070 2077
76. A.L. Birkenfeld, M. Boschmann, S. Engeli, C. Moro, A.M. Arafat, F.C. Luft, and et al. Atrial natriuretic peptide and adiponectin interactions in man PLoS One 7 2012 e43238
77. D.E. Uehlinger, P. Weidmann, M.P. Gnadinger, L. Hasler, C. Bachmann, S. Shaw, and et al. Increase in circulating insulin induced by atrial natriuretic peptide in normal humans J. Cardiovasc. Pharmacol. 8 1986 1122 1129
78. P. Ferrari, S. Shaw, W. Riesen, and P. Weidmann Plasma insulin during physiological and pathophysiological changes in atrial natriuretic factor Eur. J. Clin. Pharmacol. 42 1992 453 455
79. A.L. Birkenfeld, P. Budziarek, M. Boschmann, C. Moro, F. Adams, G. Franke, and et al. Atrial natriuretic peptide induces postprandial lipid oxidation in humans Diabetes 57 2008 3199 3204
80. H.C. Fehmann, B. Noll, R. Goke, B. Goke, M.E. Trautmann, and R. Arnold Atrial natriuretic factor has a weak insulinotropic action in the isolated perfused rat pancreas Res. Exp. Med. (Berl.) 190 1990 253 258
81. A.B. Ropero, S. Soriano, E. Tuduri, L. Marroqui, N. Tellez, B. Gassner, and et al. The atrial natriuretic peptide and guanylyl cyclase-A system modulates pancreatic beta-cell function Endocrinology 151 2010 3665 3674
82. A. Addisu, W.R. Gower Jr., M. Serrano, D. Villarreal, and J.R. Dietz Heart failure mice exhibit decreased gastric emptying and intestinal absorption Exp. Biol. Med. (Maywood) 236 2011 1454 1460
83. A. Addisu, W.R. Gower Jr., C.S. Landon, and J.R. Dietz B-type natriuretic peptide decreases gastric emptying and absorption Exp. Biol. Med. (Maywood) 233 2008 475 482
84. W.R. Gower Jr., R.W. McCuen, A. Arimura, D.A. Coy, J.R. Dietz, C.S. Landon, and et al. Reciprocal paracrine pathways link atrial natriuretic peptide and somatostatin secretion in the antrum of the stomach Regul. Pept. 110 2003 101 106
85. M. Shimada, Y. Date, M.S. Mondal, K. Toshinai, T. Shimbara, K. Fukunaga, and et al. Somatostatin suppresses ghrelin secretion from the rat stomach Biochem. Biophys. Res. Commun. 302 2003 520 525
86. Y. Chen, X.W. Ji, A.Y. Zhang, J.C. Lv, J.G. Zhang, and C.H. Zhao Prognostic value of plasma ghrelin in predicting the outcome of patients with chronic heart failure Arch. Med. Res. 45 2014 263 269
87. G. Vila, G. Grimm, M. Resl, B. Heinisch, E. Einwallner, H. Esterbauer, and et al. B-type natriuretic peptide modulates ghrelin, hunger, and satiety in healthy men Diabetes 61 2012 2592 2596
88. J.P. Herman, M.C. Langub Jr., and R.E. Watson Jr. Localization of C-type natriuretic peptide mRNA in rat hypothalamus Endocrinology 133 1993 1903 1906
89. M.C. Langub Jr., C.M. Dolgas, R.E. Watson Jr., and J.P. Herman The C-type natriuretic peptide receptor is the predominant natriuretic peptide receptor mRNA expressed in rat hypothalamus J. Neuroendocrinol. 7 1995 305 309
90. N. Yamada-Goto, G. Katsuura, K. Ebihara, M. Inuzuka, Y. Ochi, Y. Yamashita, and et al. Intracerebroventricular administration of C-type natriuretic peptide suppresses food intake via activation of the melanocortin system in mice Diabetes 62 2013 1500 1504
91. M.A. Valentino, J.E. Lin, A.E. Snook, P. Li, G.W. Kim, G. Marszalowicz, and et al. A uroguanylin-GUCY2C endocrine axis regulates feeding in mice J. Clin. Invest. 121 2013 3578 3588
92. C. Sengenes, V. Stich, M. Berlan, J. Hejnova, M. Lafontan, Z. Pariskova, and et al. Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women Int. J. Obes. Relat. Metab. Disord. 26 2002 24 32
93. S. Haufe, J. Kaminski, W. Utz, V. Haas, A. Mahler, M.A. Daniels, and et al. Differential response of the natriuretic peptide system to weight loss and exercise in overweight or obese patients J. Hypertens. 2015 (in press)
94. E. Maoz, A. Shamiss, E. Peleg, M. Salzberg, and T. Rosenthal The role of atrial natriuretic peptide in natriuresis of fasting J. Hypertens. 10 1992 1041 1044
95. N. Chainani-Wu, G. Weidner, D.M. Purnell, S. Frenda, T. Merritt-Worden, C. Kemp, and et al. Relation of B-type natriuretic peptide levels to body mass index after comprehensive lifestyle changes Am. J. Cardiol. 105 2010 1570 1576
96. R. van Kimmenade, F. van Dielen, J. Bakker, J. Nijhuis, H. Crijns, W. Buurman, and et al. Is brain natriuretic peptide production decreased in obese subjects? J. Am. Coll. Cardiol. 47 2006 886 887
97. J.V. St Peter, G.G. Hartley, M.M. Murakami, and F.S. Apple B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery Clin. Chem. 52 2006 680 685
98. E.M. Changchien, S. Ahmed, F. Betti, J. Higa, K. Kiely, T. Hernandez-Boussard, and et al. B-type natriuretic peptide increases after gastric bypass surgery and correlates with weight loss Surg. Endosc. 25 2011 2338 2343
99. A. Chen-Tournoux, A.M. Khan, A.L. Baggish, V.M. Castro, M.J. Semigran, E.L. McCabe, and et al. Effect of weight loss after weight loss surgery on plasma N-terminal pro-B-type natriuretic peptide levels Am. J. Cardiol. 106 2010 1450 1455
100. S.R. Das, M.H. Drazner, D.L. Dries, G.L. Vega, H.G. Stanek, S.M. Abdullah, and et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study Circulation 112 2005 2163 2168
101. S. Blankenberg, T. Zeller, O. Saarela, A.S. Havulinna, F. Kee, H. Tunstall-Pedoe, and et al. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project Circulation 121 2010 2388 2397
102. R. Pfister, S. Sharp, R. Luben, P. Welsh, I. Barroso, V. Salomaa, and et al. Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies PLoS Med. 8 2011 e1001112
103. I.J. Neeland, B.R. Winders, C.R. Ayers, S.R. Das, A.Y. Chang, J.D. Berry, and et al. Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile J. Am. Coll. Cardiol. 62 2013 752 760
104. H.C. Looker, M. Colombo, F. Agakov, T. Zeller, L. Groop, B. Thorand, and et al. Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes Diabetologia 58 6 2015 1363 1371
105. H. Makino, M. Mukoyama, K. Mori, T. Suganami, M. Kasahara, K. Yahata, and et al. Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice Diabetologia 49 2006 2514 2524
106. S.Z. Lutz, A.M. Hennige, S. Feil, A. Peter, A. Gerling, J. Machann, and et al. Genetic ablation of cGMP-dependent protein kinase type I causes liver inflammation and fasting hyperglycemia Diabetes 60 2011 1566 1576